Clinical data | |
---|---|
Trade names | Durezol |
AHFS/ Drugs.com | Monograph |
MedlinePlus | a609025 |
License data |
|
Routes of administration | Eye drops |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
ECHA InfoCard | 100.041.636 |
Chemical and physical data | |
Formula | C27H34F2O7 |
Molar mass | 508.559 g·mol−1 |
3D model ( JSmol) | |
| |
| |
(what is this?) (verify) |
Difluprednate, sold under the brand name Durezol, is a corticosteroid used for the treatment of post-operative ocular inflammation and pain. [1]
It was approved for medical use in the United States in June 2008. [1] [2] [3] It is available as a generic medication. [4]
Difluprednate is indicated for the treatment of inflammation and pain associated with ocular surgery; and the treatment of endogenous anterior uveitis. [1]
Difluprednate ophthalmic emulsion 0.05% is also being studied in other ocular inflammatory diseases, including a phase 3 study evaluating difluprednate for the treatment of anterior uveitis [5] [6]